Panelists discuss exciting updates on Bruton tyrosine kinase (BTK) inhibitors from the 2024 American Society of Hematology ...

Panelist discusses how HS Centers of Excellence integrating multidisciplinary care, personalized treatments, comprehensive tracking, and holistic patient support strategies can significantly improve ...

While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol ...

Accurate calculation of prostate-specific antigen doubling time can be crucial for prostate cancer treatment decisions but is ...

The upcoming Supreme Court hearing on Braidwood Management v Becerra could affect how preventive services are covered by both ...

Switching back from infliximab biosimilar SB2 to reference infliximab (Remicade) did not affect clinical disease activity or ...

In part 3 of this conversation, Karen Winkfield, MD, PhD, executive director of the Meharry-Vanderbilt Alliance, discusses ...

The clinical and financial implications of inpatient dermatology were examined, highlighting the need for systemic changes to ...

Black individuals had a 2-fold risk of cancer death related to prostate, myeloma, and stomach cancers compared with White ...

The comparable rates of remission pre- and post-pandemic suggest that COVID-19 did not negatively impact the outcomes of ...

Increasing testing for both HIV and sexually transmitted infections (STIs) can help to mitigate the incidence of both in high school students.

Aditya Bardia, MD, MPH, FASCO, medical oncologist, UCLA Health, provides new insights on the role of TROP2-directed antibody drug conjugates (ADCs) for patients with breast cancer.